Earnings just grew 10.3% at Agilent Technologies

Earnings just grew 10.3% at Agilent Technologies

Improved sales of equipment led to a 4.9%  revenue boost for Agilent Technologies during the most-recent quarter.

A recent cancer diagnostics acquisition should complement its existing product line.

Meanwhile, the stock trades at 24.0 times the company’s 2023 earnings forecast.

For a rising portfolio

Learn everything you need to know in 'How to Find the Best Growth Stocks' for FREE from The Successful Investor.

Canadian Growth Stocks: CGI Group, CAE Inc., Fortis Inc. Stock and more.

 I consent to receiving information from The Successful Investor via email. I understand I can unsubscribe from these updates at any time.

AGILENT TECHNOLOGIES INC. (New York symbol A; www.agilent.com)… Read More

Earnings just soared 23.9% at Agilent Technologies

Earnings just soared 23.9% at Agilent Technologies

Improved sales of testing equipment led to an 11.4% revenue bump for this top pick during the most-recent quarter.

Meanwhile, the stock trades at 27.6 times the company’s 2023 earnings forecast.

AGILENT TECHNOLOGIES INC. (New York symbol A; www.agilent.com) makes specialized testing equipment for medical research laboratories… Read More

Keysight continues to shine

KEYSIGHT TECHNOLOGIES INC. $176 is a buy for aggressive investors. The company (New York symbol KEYS; Aggressive Growth Portfolio, Manufacturing & Industry sector; Shares outstanding: 178.5 million; Market cap: $31.4 billion; Price-to-sales ratio: 5.9; No dividend paid; TSINetwork Rating: Average; www.keysight.com) makes an array of devices for testing… Read More

Investors continue to like this breakup

Agilent and Keysight, which it spun off in November 2014, continue to benefit investors as their split lets each focus on its own niche markets. Since the breakup, Agilent has gained 215%, while Keysight is up 336%.
AGILENT TECHNOLOGIES INC. $120 is a buy. The company (New York… Read More